New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Saturday, Nov 21, 2026
Export TVRD’s income statement to Excel — free account
Tvardi Therapeutics, Inc.
TVRDTvardi Therapeutics, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $7.1 million, down 66.0% from fiscal 2023.
- Revenue
- +20.3%
- EPS
- n/m
- Free cash flow
- n/m
Quarter to September 2026, against a year earlier
0.99
0.04
+4.21%
After hours trading: 0.97, down 2.02%, last trade Fri 7:28pm Eastern.
Follow TVRD
Alert me
What it owns vs. what it owes End of fiscal 2025, Dec 31, 2025
Debt has risen from $3.4M to $30.3M since FY19. Shareholders’ equity is 65.3% of the balance sheet. What is a balance sheet?
Owns
$535.0KLong-term assets
$727.0KOther short-term assets
$30.8MCash & short-term investments
Funded by
$20.9MShareholders’ equity
$11.1MOther liabilities
Debt is 0.00% of the total; shareholders’ equity 65.3%.
Net cash fell from 65% of assets to 4% since FY19.
Net debt ÷ assets (right axis)
| FY19 | FY20 | FY21 | FY22 | FY24 | |
|---|---|---|---|---|---|
| Total assets | $233M | $271M | $247M | $182M | $35M |
| Net debt (debt less cash) | −$152M | −$177M | −$165M | −$144M | −$1.4M |
| Net debt ÷ assets (right axis) | −65.1% | −65.4% | −66.8% | −79.0% | −3.8% |
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash and Short Term Investments |
58.98 | 92.57 | 161.74 | 155.01 | 180.93 | 167.04 | 145.81 | 101.17 | 31.61 | 30.81 |
Receivables |
0.94 | 0.85 | 1.59 | 1.79 | 2.06 | 1.15 | 4.45 | 4.02 | 4.50 | — |
Inventory |
— | — | — | — | — | 2.58 | 2.38 | 2.82 | 0.90 | — |
Total current assets |
61.45 | 95.06 | 168.14 | 165.66 | 195.07 | 173.29 | 168.91 | 116.16 | 31.69 | 31.54 |
Property, Plant, Equpment (Net) |
1.61 | 1.18 | 0.88 | 0.70 | 0.84 | 0.63 | 0.43 | 3.32 | 0.08 | 0.05 |
Long-Term Investments |
0.77 | 0.77 | 21.40 | 63.16 | 70.57 | 69.75 | 11.35 | — | — | — |
Goodwill and Intangible Assets (Total) |
— | — | — | — | — | — | — | — | 0.39 | 0.32 |
Long-term assets (Other) |
0.77 | 0.77 | 0.41 | 0.41 | 0.41 | 0.41 | — | 1.50 | 0.02 | 0.02 |
Total non-current assets |
2.38 | 1.95 | 22.68 | 67.30 | 76.09 | 73.77 | 13.33 | 9.69 | 3.51 | 0.54 |
Total Assets |
63.83 | 97.00 | 190.82 | 232.96 | 271.16 | 247.06 | 182.24 | 125.84 | 35.20 | 32.07 |
Accounts Payable |
4.74 | 3.83 | 4.37 | 9.10 | 4.89 | 5.63 | 9.60 | — | 2.19 | 3.22 |
Accrued Expenses |
11.53 | 8.51 | 13.62 | 19.67 | 16.88 | 15.86 | 21.54 | 25.59 | 8.08 | 7.71 |
Current Revenue (Deferred) |
— | — | 26.83 | 22.26 | — | — | — | — | — | — |
Total current liabilities |
11.53 | 8.51 | 40.45 | 42.89 | 18.48 | 17.62 | 23.46 | 25.59 | 10.37 | 11.04 |
Long Term Debt (Total) |
— | — | — | 3.35 | 3.67 | 1.92 | — | — | 30.26 | — |
Non-current Revenue (Deferred) |
— | — | 15.18 | — | — | — | — | — | — | — |
Preferred Shares of Subsidiary (Mandatory, Redeemable) |
— | — | — | — | — | — | — | — | 85.50 | — |
Non-current Liabilities (Other) |
1.57 | 1.72 | 1.56 | 0.00 | 0.00 | — | — | 37.08 | 44.45 | — |
Total non-current liabilities |
1.57 | 1.72 | 16.75 | 3.35 | 3.67 | 1.92 | — | 43.17 | 115.96 | 0.09 |
Total liabilities |
13.10 | 10.22 | 57.19 | 46.25 | 22.16 | 19.53 | 23.46 | 68.76 | 126.33 | 11.13 |
Additional Paid In Capital |
212.87 | 307.16 | 428.06 | 587.22 | 641.20 | 708.59 | 726.63 | 742.09 | 1.10 | 131.38 |
Common Stock (Net) |
0.03 | 0.03 | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 | 0.01 | 0.00 | 0.01 |
Retained Earnings |
(162.17) | (220.34) | (294.35) | (400.73) | (392.32) | (480.76) | (566.23) | (684.74) | (92.24) | (110.45) |
Common Equity (Total) |
50.73 | 86.78 | 133.63 | 186.71 | 249.00 | 227.52 | 158.78 | 57.09 | (91.13) | 20.95 |
Shareholders Equity (Total) |
50.73 | 86.78 | 133.63 | 186.71 | 249.00 | 227.52 | 158.78 | 57.09 | (91.13) | 20.95 |
Shareholders Equity and Liabilities (Total) |
63.83 | 97.00 | 190.82 | 232.96 | 271.16 | 247.06 | 182.24 | 125.84 | 35.20 | 32.07 |
Shares (Common) |
0.76 | 0.91 | 1.10 | 1.30 | 1.38 | 1.48 | 1.49 | 1.51 | 2.58 | 9.38 |
Shares (Preferred) |
— | — | — | — | — | — | — | — | 3.96 | — |
Shareholders Equity (Tangible) |
50.73 | 86.78 | 133.63 | 186.71 | 249.00 | 227.52 | 158.78 | 57.09 | (91.52) | 20.62 |
Net Debt |
(58.98) | (92.57) | (161.74) | (151.65) | (177.25) | (165.12) | (145.81) | (101.17) | (1.35) | (30.81) |
Total Debt |
— | — | — | 3.35 | 3.67 | 1.92 | 1.92 | — | 30.26 | — |
In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 17, 2026